Upstart Plunged February: Key Drivers Behind the Selloff
February brought a sharp drop for Upstart as investors weighed margins, product risk, and leadership changes. This de...
Auto rebalancing and capital gains management covers how automated tweaks can curb tax impact while preserving strategy.
28,070 articlesFebruary brought a sharp drop for Upstart as investors weighed margins, product risk, and leadership changes. This de...
A stock delivering 81% gains in six months faces another chapter after March 18. This guide breaks down the story, th...
Nvidia pulls off a landmark $20B Groq deal that could reshape AI inference in 2026. This piece breaks down the tech, ...
When a company's top medical officer sells a large block and leaves with a zero direct stake, investors notice. This ...
When rates trend downward, cash-flow investors face a tougher math as prices rise and competition heats up. This guid...
When wealth and fame meet legal drama, discovery battles can reshape costs and outcomes. This article breaks down the...
A convincing fake bank call sent a Virginia resident on a cash handoff, revealing how scammers use authority and urge...
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
Jim Cramer argues that South Korea mispricing SK Hynix reflects trader psychology rather than weak fundamentals. He r...
New real estate investors often hit a wall when income is inconsistent. DSCR loans offer a financing strategy grounde...
A director sold 45,000 LUMN shares, triggering questions about Lumen Technologies stock sell signals. This article br...
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...